Aeris Helps Wisepill Use IoT to Improve TB Treatment Outcomes

“Tuberculosis, particularly drug-resistant TB, affects patients around the world, primarily in under-served communities. The Wisepill approach, using IoT technology to improve medication adherence, has shown marked success wherever it has been adopted. Our partnership with Aeris, and its global connectivity service, enables us to provide the same patient experience from urban Kiev in Ukraine to rural Uganda, and to address the challenge of TB treatment with a creative and cost-effective solution.” 

Lloyd Marshall, CEO and Founder, Wisepill Technologies.  Read more